Histone H3 Lysine 18 Lactylation Promotes Cardiac Hypertrophy Through Activating GATA Binding Protein 4 Signaling
MedComm · 2025-11 · 6 (11)
DOI: 10.1002/mco2.70421 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 22.10.2025. Verfasst von Mingzhu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine Shanghai China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Histone lactylation, particularly histone H3 lysine 18 lactylation (H3K18la), modulates gene expression profile in diverse cellular processes, which has emerged as a critical factor in cardiovascular disease pathogenesis. However, its specific role in cardiac hypertrophy remains unclear. This study investigates the mechanism of H3K18la in promoting cardiac hypertrophy using transverse aortic constriction‐induced mice model and a phenylephrine‐induced hypertrophic cardiomyocyte model. We found that elevated levels of Pan‐Kla and H3K18la were detected in hypertrophic left ventricular tissues and cardiomyocytes, accompanied by increased heart and left ventricle weights, enlarged cardiomyocyte cross‐sectional areas and heightened expression of ANP, BNP, and β‐MHC. Clinical observations revealed a positive correlation between serum lactate levels and hypertrophic cardiomyopathy in patients. Furthermore, inhibition of lactylation reversed these effects, suggesting a direct role of H3K18la in hypertrophic gene expression. Mechanistically, H3K18la was found to interact with GATA4, enhancing its transcriptional activity as demonstrated by increased ANP promoter activity. Moreover, suppression of GATA4 mitigated the hypertrophic response, highlighting its crucial role downstream of H3K18la. Our findings identify H3K18la lactylation as a novel epigenetic mechanism driving cardiac hypertrophy through GATA4 activation. This implicates potential therapeutic targets for hypertrophic heart diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine Shanghai China.
- Academy of Integrative Medicine Shanghai University of Traditional Chinese Medicine Shanghai China.
ORCID-Profile: Mingzhu Wang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, M., Liu, Z., Ma, Y., Li, D., Lin, Y., Wang, Y., Fu, D., Guo, H., & Hu, L. (2025). Histone H3 Lysine 18 Lactylation Promotes Cardiac Hypertrophy Through Activating GATA Binding Protein 4 Signaling. MedComm, 6(11). https://doi.org/10.1002/mco2.70421
Vancouver
Wang M, Liu Z, Ma Y, Li D, Lin Y, Wang Y, et al. Histone H3 Lysine 18 Lactylation Promotes Cardiac Hypertrophy Through Activating GATA Binding Protein 4 Signaling. MedComm. 2025;6(11). doi:10.1002/mco2.70421
BibTeX
@article{Wang2025,
author = {Wang, Mingzhu and Liu, Zixian and Ma, Yongbo and Li, Da and Lin, Yuan and Wang, Yani and Fu, Deyu and Guo, Haidong and Hu, Liang},
title = {Histone H3 Lysine 18 Lactylation Promotes Cardiac Hypertrophy Through Activating GATA Binding Protein 4 Signaling},
journal = {MedComm},
year = {2025},
volume = {6},
number = {11},
doi = {10.1002/mco2.70421}
}
EUVIMED